Marquis Vawter

Dr. Marquis Vawter


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Annals of Medicine
Verified
Journal Article
Closed access
LSLing Shao
Ling Shao
MMMaureen V. Martin
Maureen V. Martin
SWStanley J. Watson
Stanley J. Watson
ASAlan Schatzberg
Alan Schatzberg
HAHuda Akil
Huda Akil
MVMarquis Vawter
Marquis Vawter
Recent findings of mitochondrial abnormalities in brains from subjects with neurological disorders have led to a renewed search for mitochondrial abnormalities in psychiatric disorders. A growing body of evidence suggests that there is mitochondrial dysfunction in schizophrenia, bipolar disorder, and major depressive disorder, including evidence from electron microscopy, imaging, gene expression, genotyping, and sequencing studies. Specific evidence of dysfunction such as increased common deletion and decreased gene expression in mitochondria in psychiatric illnesses suggests that direct examination of mitochondrial DNA from postmortem brain cells may provide further details of mitochondrial alterations in psychiatric disorders.

1 July 2001 in Brain Research Bulletin
Verified
Journal Article
Closed access
MVMarquis Vawter
Marquis Vawter
TBTanya Barrett
Tanya Barrett
CCChristopher Cheadle
Christopher Cheadle
BSBoris P Sokolov
Boris P Sokolov
WWWilliam H Wood
William H Wood
KBKevin G Becker
Kevin G Becker

17 May 2010 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
BRBrandi Rollins
Brandi Rollins
MMMaureen V. Martin
Maureen V. Martin
LMLing Morgan
Ling Morgan
MVMarquis Vawter
Marquis Vawter

29 October 2003 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
MVMarquis Vawter
Marquis Vawter
SESimon Evans
Simon Evans
PCPrabhakara Choudary
Prabhakara Choudary
HTHiroaki Tomita
Hiroaki Tomita
JMJim Meador-Woodruff
Jim Meador-Woodruff
WBWilliam E Bunney
William E Bunney
Gender differences in brain development and in the prevalence of neuropsychiatric disorders such as depression have been reported. Gender differences in human brain might be related to patterns of gene expression. Microarray technology is one useful method for investigation of gene expression in brain. We investigated gene expression, cell types, and regional expression patterns of differentially expressed sex chromosome genes in brain. We profiled gene expression in male and female dorsolateral prefrontal cortex, anterior cingulate cortex, and cerebellum using the Affymetrix oligonucleotide microarray platform. Differentially expressed genes between males and females on the Y chromosome (DBY, SMCY, UTY, RPS4Y, and USP9Y) and X chromosome (XIST) were confirmed using real-time PCR measurements. In situ hybridization confirmed the differential expression of gender-specific genes and neuronal expression of XIST, RPS4Y, SMCY, and UTY in three brain regions examined. The XIST gene, which silences gene expression on regions of the X chromosome, is expressed in a subset of neurons. Since a subset of neurons express gender-specific genes, neural subpopulations may exhibit a subtle sexual dimorphism at the level of differences in gene regulation and function. The distinctive pattern of neuronal expression of XIST, RPS4Y, SMCY, and UTY and other sex chromosome genes in neuronal subpopulations may possibly contribute to gender differences in prevalence noted for some neuropsychiatric disorders. Studies of the protein expression of these sex-chromosome-linked genes in brain tissue are required to address the functional consequences of the observed gene expression differences.

17 March 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BRBrandi Rollins
Brandi Rollins
MMMaureen V. Martin
Maureen V. Martin
PSP. Adolfo Sequeira
P. Adolfo Sequeira
EMEmily A. Moon
Emily A. Moon
LMLing Z. Morgan
Ling Z. Morgan
MVMarquis Vawter
Marquis Vawter
Mitochondria provide most of the energy for brain cells by the process of oxidative phosphorylation. Mitochondrial abnormalities and deficiencies in oxidative phosphorylation have been reported in individuals with schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD) in transcriptomic, proteomic, and metabolomic studies. Several mutations in mitochondrial DNA (mtDNA) sequence have been reported in SZ and BD patients. Dorsolateral prefrontal cortex (DLPFC) from a cohort of 77 SZ, BD, and MDD subjects and age-matched controls (C) was studied for mtDNA sequence variations and heteroplasmy levels using Affymetrix mtDNA resequencing arrays. Heteroplasmy levels by microarray were compared to levels obtained with SNaPshot and allele specific real-time PCR. This study examined the association between brain pH and mtDNA alleles. The microarray resequencing of mtDNA was 100% concordant with conventional sequencing results for 103 mtDNA variants. The rate of synonymous base pair substitutions in the coding regions of the mtDNA genome was 22% higher (p = 0.0017) in DLPFC of individuals with SZ compared to controls. The association of brain pH and super haplogroup (U, K, UK) was significant (p = 0.004) and independent of postmortem interval time. Focusing on haplogroup and individual susceptibility factors in psychiatric disorders by considering mtDNA variants may lead to innovative treatments to improve mitochondrial health and brain function.

25 April 2006 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
MVMarquis Vawter
Marquis Vawter
HTHiroaki Tomita
Hiroaki Tomita
FMF Meng
F Meng
BBB Bolstad
B Bolstad
JLJ Li
J Li
WBW E Bunney
W E Bunney